Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 1.00 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 0.67 |
| ▸ | CA12 | O43570 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 2/20 | 0.67 |
| ▸ | CA4 | P22748 | 2/20 | 0.67 |
| ▸ | CA6 | P23280 | 2/20 | 0.67 |
| ▸ | CA5A | P35218 | 2/20 | 0.67 |
| ▸ | CA7 | P43166 | 2/20 | 0.67 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.67 |
| ▸ | HTR6 | P50406 | 3/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25973 | 0.98 | F2 (1.00) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Hydrochloric Acid SCHEMBL6425431 | 0.98 | F2 (1.00) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Hydrochloric Acid SCHEMBL28825226 | 0.96 | F2 (0.96) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Hydrochloric Acid SCHEMBL723369 | 0.96 | F2 (0.92) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Hypochlorous Acid SCHEMBL17004810 | 0.94 | F2 (0.89) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| SCHEMBL31631413 | 0.83 | F2 (0.71) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| SCHEMBL6680951 | 0.82 | HTR6 (0.84) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Benzamidine SCHEMBL3427811 | 0.81 | F2 (0.66) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| Hydrochloric Acid SCHEMBL21199324 | 0.80 | F2 (0.70) | F2TMPRSS4CYP1A2TP53CYP2D6 | |
| SCHEMBL142107 | 0.80 | CA2 (1.00) | F2TMPRSS4CYP1A2TP53CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4372 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081365-A | Alpha-hemolysin recombinant protein and prokaryotic expression method thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4744663-A2 | SKIN COMPOSITION | Eaderm Co., Ltd. (JP) | 2026-05-20 | — | — | EP | claimed |
| US-20260125640-A1 | ACELLULAR PLACENTAL PREPARATIONS | PLAKOUS THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | claimed |
| US-12584161-B2 | Stabilization of nucleic acids in urine | STRECK LLC (US) | 2026-03-24 | — | — | US | claimed |
| US-20260041663-A1 | PREVENTION OF ROSACEA INFLAMMATION | UNIV CALIFORNIA (US) | 2026-02-12 | — | — | US | claimed |
| EP-4662310-A2 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES FOR MULTIPLEX ANALYSIS | Parse Biosciences, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| US-12453346-B2 | Stabilization of whole blood at room temperature | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-10-28 | — | — | US | claimed |
| US-20250281579-A1 | Methods and Compositions for Oral Administration of Proteins | ORAMED PHARMACEUTICALS INC (IL) | 2025-09-11 | — | — | US | claimed |
| US-12383554-B2 | Compositions and methods to protect mammalian tissue against cold and other metabolic stresses | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2025-08-12 | — | — | US | claimed |
| EP-4008400-B1 | ACELLULAR PLACENTAL PREPARATIONS | PLAKOUS THERAPEUTICS INC (US) | 2025-06-18 | — | — | EP | claimed |
| EP-1221948-A2 | USE OF COMPOSITIONS FOR THE CARING TREATMENT OF THE SKIN | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-07-17 | — | — | EP | claimed |
| WO-2002030453-A1 | METHODS OF INHIBITING ANGIOGENESIS USING NADPH OXIDASE INHIBITORS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2002-04-18 | — | — | WO | claimed |
| US-20020018802-A1 | Wound coverings for removal of interfering factors from wound fluid | MEYER-INGOLD WOLFGANG (DE) | 2002-02-14 | — | — | US | claimed |
| US-20020012958-A1 | INCREASING THE FVII SENSITIVITY OF A THROMBOPLASTIN REAGENT | DADE BEHRING MARBURG GMBH (DE) | 2002-01-31 | — | — | US | claimed |
| WO-2001089449-A2 | PHOSPHOLIPASE D EFFECTORS FOR THERAPY AND SCREENING | WILLIGER BEN (IL) | 2001-11-29 | — | — | WO | claimed |
| WO-2001028536-A2 | USE OF COMPOSITIONS FOR THE CARING TREATMENT OF THE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-04-26 | — | — | WO | claimed |
| WO-2001029163-A1 | CLEANING AGENTS WHICH CONTAIN SURFACTANTS AND ENZYME INHIBITORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-04-26 | — | — | WO | claimed |
| EP-0945144-A2 | Wound dressing for removal of interference factors from wound exudate | Beiersdorf Aktiengesellschaft (DE) | 1999-09-29 | — | — | EP | claimed |
| EP-0878551-A2 | Enhancement of the factor-VII sensitivity of a thromboplastin reagent | Dade Behring Marburg GmbH (DE) | 1998-11-18 | — | — | EP | claimed |
| WO-1994016082-A1 | X-PROLYL-DIPEPTIDYL-AMINOPEPTIDASE FROM LACTOBACILLUS DELBRÜCKII SSP. LACTIS, NUCLEIC ACIDS CODING FOR THE SAME AND ITS USE IN FERMENTED FOODSTUFF PREPARATION PROCESSES | COMMUNAUTE ECONOMIQUE EUROPEENNE (CEE) (LU) | 1994-07-21 | — | — | WO | claimed |